Insulin ResistanceNCT02582606
Meal Pattern and Metabolic Parameters
A study testing Regular meal pattern and Irregular meal pattern in people with Insulin Resistance, run by University of Nottingham at 1 site in United Kingdom.
Trial summary
In this study investigators will compare the health effect of two different meal patterns. In one, participants will consume food according to an 'irregular meal pattern' (minimum 3 meals, maximum 9 meals per day) and in the other 'regular meal pattern' (6 meals per day) for two weeks. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Insulin Resistance
- What is being tested?
- Regular meal pattern and Irregular meal pattern
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 9 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Feb 2014to May 2015
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Healthy;
- BMI 28 - 40 kg/m2
- Insulin resistance, HOMA ≥ 1.5
- Weight stable during the last 3 months (self-reported weight change < ± 2 kg)
Who cannot join
- history of serious disease as assessed by a medical screening questionnaire
- taking any medication except for the oral contraceptive pill.
- Smokers
- high alcohol consumers (< 2-3 units/day),
- pregnant/lactating
- irregular menstrual cycles
Show all 10Show fewer
- dieting/seeking to lose weight
- clinical symptoms of depression (Beck)
- eating disorder (EAT-26)
- allergy or intolerance to any of the foods provided during each study.
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
David Greenfield Human Physiology Unit, University of Nottingham Medical School
Nottingham, Notts, NG72UH
About this study
Official title: Effects of the Constancy of Daily Meal Pattern on Energy Balance, Glucose Profiles and Plasma Lipoproteins in Obese Women
In this study investigators will compare the health effect of two different meal patterns. In one, participants will consume food according to an 'irregular meal pattern' (minimum 3 meals, maximum 9 meals per day) and in the other 'regular meal pattern' (6 meals per day) for two weeks. The energy requirement of the participants will be calculated to maintain body weight during the study. Participants will be provided with all the food to be consumed during the study.
Initially, interested individuals will attend a screening visit in which they will complete questionnaires on medical health, eating habits and physical activity. Height, weight and waist circumference will be measured at this visit. Thereafter, participants will be assigned to a 2-week period following one of the two meal-patterns. There will be a 2-week period between the two interventions when they will consume their normal diet and at the end of this, participants will undertake the next meal pattern. During the two phases participants will be asked to wear an armband (which detects movement and measures heat loss), to assess their energy expenditure and an interstitial glucose monitoring device will be worn for seven days. Before and after each 2-week intervention, participants will come to the laboratory for a mixed-meal tolerance test. Blood samples will be obtained before and for 3hrs after eating to evaluate the health effects of the meal patterns. Energy expenditure will be measured by ventilated-hood indirect calorimetry and the armband device. At the end of the 3hr post prandial period, participants will be offered an ad libitum pasta lunch and be asked to eat until they feel comfortably full.
During each of the 2-week periods, participants will be asked to record their food intake and record their appetite sensations on specific days.
Read the detailed description
Background. Greater variation in meal pattern from day to day might affect energy balance and, in consequence, the control of body weight. However, studies which have evaluated the impact of an irregular meal pattern on energy metabolism, in adults, are few. Several experimental studies by Farshchi et al. have shown that there are potentially important negative health consequences associated with erratic/irregular eating patterns. Higher fasting levels of total-cholesterol and low density lipoprotein (LDL)-cholesterol, a decrease in thermic effect of food (TEF), and reduced insulin sensitivity, were observed in healthy women after 14 days of irregular eating. Subsequent studies have confirmed this in overweight subjects and also provided evidence of alterations in subjective appetite which may influence ad-libitum food intake (Lara et al, unpublished).
Recently, experimenters have shown a decrease in thermogenesis in response to a test meal, and greater postprandial blood glucose concentration in 11 normal weight women following two-weeks of irregular eating in contrast to a regular pattern.
The present study will study the effect of an irregular meal pattern in obese women who demonstrate fasting insulin resistance (IR).
Aims:
to investigate the effects of meal pattern on energy expenditure, postprandial thermogenesis, postprandial blood glucose, fasting lipid profile and fasting insulin sensitivity in obese women with insulin resistance.
Experimental protocol. 10 women with a homeostatic model assessment - insulin resistance (HOMA-IR) ≥1.8, body mass index between 28 and 40 kg/m2, aged 18-45 years, and who are otherwise healthy, will be recruited. Interested individuals will have an initial medical screening to confirm suitability. Those who are recruited will be asked to then complete a 7 days food diary before participating in the study. The whole study will last for a total of 6 weeks. During the first 2 weeks participants will adopt one of two meal patterns, followed by a two-week washout period during which they resume their habitual diet and meal pattern. A second 2-week intervention will then follow, in which the alternative meal pattern is adopted. The meal patterns will be 1) regular - 6 daily meals or snacks for 2 weeks, or 2) irregular - a different number (between 3 and 9) of meals/snacks every day. Allocation of the order in which the diets are tested will be randomized at the point of recruitment with participant number assigned sequentially. All foods to be consumed during weeks1, 2, 5 and 6 will be provided free of charge, and will comprise foods commonly consumed in the British diet, in quantities designed to keep body weight constant during the study. Participants will complete food diaries over the whole study period. They will be asked to wear a 'SenseWear' armband (SWA) device (attached to an upper arm) to allow physical activity and energy expenditure to be estimated during weeks1, 2, 5 and 6. Participants will attend the laboratory on the 6th day of each intervention phase to have a continuous interstitial glucose monitoring probe inserted in the subcutaneous abdominal fat pad at the level of the umbilicus. Participants will measure their blood glucose four times a day, using a fingerprick sample and pocket glucose analyser, to calibrate the continuous glucose monitor. After three days participants will be asked to come back to have this device removed.
Subjective appetite (hunger, fullness, etc.) will be assessed using visual analogue scales (VAS) during the intervention (at the end of each week, and whilst the glucose monitor is being worn).
Before and after each intervention period, participants will visit the laboratory after fasting overnight. At 8:30 am a cannula will be inserted into a hand vein, with the hand placed in a hot-air box, for subsequent blood sampling. Indirect calorimetry will be performed to determine energy expenditure, carbohydrate and lipid oxidation rates and changes in the thermic response to a milkshake test drink providing 10 kcals/kg body weight, and comprising 35% of energy as fat, 15% as protein, and 50% as carbohydrate. The SWA device will also be placed on the upper left arm to estimate energy expenditure during the laboratory visit. Blood samples will be obtained before and every 15 minutes for 3 hours after eating. Indirect calorimetry and SWA will be measured concurrently for the duration of the laboratory visit. Fasting blood samples will be used to measure total-, high density lipoprotein (HDL)-, LDL-, and very low density lipoprotein (VLDL)-cholesterol, triglycerides, glucose and insulin. Blood samples obtained after the test drink will also be used to measure glucose, insulin and hormones related to appetite. After the 3hr postprandial period, a test meal (pasta) will be provided as ad-libitum meal and participants will be asked to fill VAS to assess subjective appetite sensations.
Measurable end points of the study
- 24hr Energy expenditure during the two phases (irregular versus regular meal pattern)
- Fasting lipids, insulin, glucose and glucose profiles during the continuous monitoring
- Insulin, glucose and gut hormone (Glucagon-Like Peptide 1, Ghrelin and Peptide YY) responses to the test drink
- Postprandial thermogenic response to a test drink
- Ratings of subjective appetite during the study Sample size and statistical power Using 1 sample t-test model, power calculated at the level of 0.8. Primary end point = difference in thermic effect of food 'TEF' (kcal/min) over 180min. Results obtained from study previous studies indicated the incremental area under the TEF curve after regular eating was 25.8 (SD 6.8) kcal and after irregular eating was 14.8 (SD 11.7) kcal. With a cross-over design, 10 subjects in each group would be able to detect a change in TEF with the power of 80% at the level of 0.05 significance.
- Conditions
- Insulin Resistance
- Being tested
- Regular meal pattern, Irregular meal pattern
- Keywords
- Insulin Resistance, Meal pattern, Obese
- Medical subject headings
- Insulin Resistance, Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Regular meal patternOther
a 14-day period of eating 6 meal per day
Irregular meal patternOther
a 14-day period of eating between 3 and 9 meal per day
| Study group | Role | What they receive |
|---|---|---|
| Regular | Experimental | Regular meal pattern Receives: Other: Regular meal pattern |
| Irregular | Experimental | Irregular meal pattern Receives: Other: Irregular meal pattern |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in fasting insulin sensitivity, as measured by HOMA-IR
insulin sensitivity assessed using fasting circulating insulin and glucose concentration and the HOMA-insulin resistance (IR) index
Measured: 14 days
Secondary outcomes (5)
Change in postprandial circulating insulin concentration
assessed during the mixed meal tolerance test using serum insulin concentration
Measured: 14 days
Change in thermic effect of food
fasting and postprandial energy expenditure assessed by indirect calorimetry during laboratory visits
Measured: 14 days
Change in subjective appetite
Will be assessed by Visual Analogue Scale during the intervention and throughout the mixed meal tolerance test.
Measured: 14 days
Change in appetite hormones
Circulating level of leptin, adiponectin, glucagon-like peptide1, peptide YY and ghrelin before and during the mixed meal tolerance test.
Measured: 14 days
Change in fasting cholesterol
will be assessed before each mixed meal tolerance test
Measured: 14 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Oct 2015 (estimated)
- Study startFeb 2014
- Primary completionOct 2014
- Study completionMay 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Insulin ResistanceStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 9 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Nottingham
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Elizabeth Simpson, University of Nottingham
- Investigators
- Ian A Macdonald, PhD, Principal investigator, University of Nottingham
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02582606
- Sponsor's protocol ID
- P3/15
- Status last verified
- Mar 2018
- First submitted
- 16 Oct 2015
- Last updated
- 27 Mar 2018
- Results posted
- No
- Data monitoring committee
- No
Publications
Farshchi HR, Taylor MA, Macdonald IA. Decreased thermic effect of food after an irregular compared with a regular meal pattern in healthy lean women. Int J Obes Relat Metab Disord. 2004 May;28(5):653-60. doi: 10.1038/sj.ijo.0802616.
PubMed 15085170Farshchi HR, Taylor MA, Macdonald IA. Regular meal frequency creates more appropriate insulin sensitivity and lipid profiles compared with irregular meal frequency in healthy lean women. Eur J Clin Nutr. 2004 Jul;58(7):1071-7. doi: 10.1038/sj.ejcn.1601935.
PubMed 15220950Farshchi HR, Taylor MA, Macdonald IA. Beneficial metabolic effects of regular meal frequency on dietary thermogenesis, insulin sensitivity, and fasting lipid profiles in healthy obese women. Am J Clin Nutr. 2005 Jan;81(1):16-24. doi: 10.1093/ajcn/81.1.16.
PubMed 15640455Alhussain MH, Macdonald IA, Taylor MA. Impact of isoenergetic intake of irregular meal patterns on thermogenesis, glucose metabolism, and appetite: a randomized controlled trial. Am J Clin Nutr. 2022 Jan 11;115(1):284-297. doi: 10.1093/ajcn/nqab323.
PubMed 34555151
Study at a glance
From the registry record, last updated by the sponsor on 27 Mar 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of the Constancy of Daily Meal Pattern on Energy Balance, Glucose Profiles and Plasma Lipoproteins in Obese Women
- ClinicalTrials.gov ID
- NCT02582606
- Acronym / sponsor ID
- P3/15
- Conditions
- Insulin Resistance
- Keywords
- Insulin Resistance, Meal pattern, Obese
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 9 participants (actual)
- Lead sponsor
- University of NottinghamUniversity, hospital or other
- Study start
- Feb 2014
- Primary completion
- Oct 2014 (actual)
- Study completion
- May 2015 (actual)
- First posted
- 21 Oct 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study investigators will compare the health effect of two different meal patterns. In one, participants will consume food according to an 'irregular meal pattern' (minimum 3 meals, maximum 9 meals per day) and in the other 'regular meal pattern' (6 meals per day) for two weeks. The energy requirement of the participants will be calculated to maintain body weight during the study. Participants will be provided with all the food to be consumed during the study.
Initially, interested individuals will attend a screening visit in which they will complete questionnaires on medical health, eating habits and physical activity. Height, weight and waist circumference will be measured at this visit. Thereafter, participants will be assigned to a 2-week period following one of the two meal-patterns. There will be a 2-week period between the two interventions when they will consume their normal diet and at the end of this, participants will undertake the next meal pattern. During the two phases participants will be asked to wear an armband (which detects movement and measures heat loss), to assess their energy expenditure and an interstitial glucose monitoring device will be worn for seven days. Before and after each 2-week intervention, participants will come to the laboratory for a mixed-meal tolerance test. Blood samples will be obtained before and for 3hrs after eating to evaluate the health effects of the meal patterns. Energy expenditure will be measured by ventilated-hood indirect calorimetry and the armband device. At the end of the 3hr post prandial period, participants will be offered an ad libitum pasta lunch and be asked to eat until they feel comfortably full.
During each of the 2-week periods, participants will be asked to record their food intake and record their appetite sensations on specific days.
Detailed description
Background. Greater variation in meal pattern from day to day might affect energy balance and, in consequence, the control of body weight. However, studies which have evaluated the impact of an irregular meal pattern on energy metabolism, in adults, are few. Several experimental studies by Farshchi et al. have shown that there are potentially important negative health consequences associated with erratic/irregular eating patterns. Higher fasting levels of total-cholesterol and low density lipoprotein (LDL)-cholesterol, a decrease in thermic effect of food (TEF), and reduced insulin sensitivity, were observed in healthy women after 14 days of irregular eating. Subsequent studies have confirmed this in overweight subjects and also provided evidence of alterations in subjective appetite which may influence ad-libitum food intake (Lara et al, unpublished).
Recently, experimenters have shown a decrease in thermogenesis in response to a test meal, and greater postprandial blood glucose concentration in 11 normal weight women following two-weeks of irregular eating in contrast to a regular pattern.
The present study will study the effect of an irregular meal pattern in obese women who demonstrate fasting insulin resistance (IR).
Aims:
to investigate the effects of meal pattern on energy expenditure, postprandial thermogenesis, postprandial blood glucose, fasting lipid profile and fasting insulin sensitivity in obese women with insulin resistance.
Experimental protocol. 10 women with a homeostatic model assessment - insulin resistance (HOMA-IR) ≥1.8, body mass index between 28 and 40 kg/m2, aged 18-45 years, and who are otherwise healthy, will be recruited. Interested individuals will have an initial medical screening to confirm suitability. Those who are recruited will be asked to then complete a 7 days food diary before participating in the study. The whole study will last for a total of 6 weeks. During the first 2 weeks participants will adopt one of two meal patterns, followed by a two-week washout period during which they resume their habitual diet and meal pattern. A second 2-week intervention will then follow, in which the alternative meal pattern is adopted. The meal patterns will be 1) regular - 6 daily meals or snacks for 2 weeks, or 2) irregular - a different number (between 3 and 9) of meals/snacks every day. Allocation of the order in which the diets are tested will be randomized at the point of recruitment with participant number assigned sequentially. All foods to be consumed during weeks1, 2, 5 and 6 will be provided free of charge, and will comprise foods commonly consumed in the British diet, in quantities designed to keep body weight constant during the study. Participants will complete food diaries over the whole study period. They will be asked to wear a 'SenseWear' armband (SWA) device (attached to an upper arm) to allow physical activity and energy expenditure to be estimated during weeks1, 2, 5 and 6. Participants will attend the laboratory on the 6th day of each intervention phase to have a continuous interstitial glucose monitoring probe inserted in the subcutaneous abdominal fat pad at the level of the umbilicus. Participants will measure their blood glucose four times a day, using a fingerprick sample and pocket glucose analyser, to calibrate the continuous glucose monitor. After three days participants will be asked to come back to have this device removed.
Subjective appetite (hunger, fullness, etc.) will be assessed using visual analogue scales (VAS) during the intervention (at the end of each week, and whilst the glucose monitor is being worn).
Before and after each intervention period, participants will visit the laboratory after fasting overnight. At 8:30 am a cannula will be inserted into a hand vein, with the hand placed in a hot-air box, for subsequent blood sampling. Indirect calorimetry will be performed to determine energy expenditure, carbohydrate and lipid oxidation rates and changes in the thermic response to a milkshake test drink providing 10 kcals/kg body weight, and comprising 35% of energy as fat, 15% as protein, and 50% as carbohydrate. The SWA device will also be placed on the upper left arm to estimate energy expenditure during the laboratory visit. Blood samples will be obtained before and every 15 minutes for 3 hours after eating. Indirect calorimetry and SWA will be measured concurrently for the duration of the laboratory visit. Fasting blood samples will be used to measure total-, high density lipoprotein (HDL)-, LDL-, and very low density lipoprotein (VLDL)-cholesterol, triglycerides, glucose and insulin. Blood samples obtained after the test drink will also be used to measure glucose, insulin and hormones related to appetite. After the 3hr postprandial period, a test meal (pasta) will be provided as ad-libitum meal and participants will be asked to fill VAS to assess subjective appetite sensations.
Measurable end points of the study
- 24hr Energy expenditure during the two phases (irregular versus regular meal pattern)
- Fasting lipids, insulin, glucose and glucose profiles during the continuous monitoring
- Insulin, glucose and gut hormone (Glucagon-Like Peptide 1, Ghrelin and Peptide YY) responses to the test drink
- Postprandial thermogenic response to a test drink
- Ratings of subjective appetite during the study Sample size and statistical power Using 1 sample t-test model, power calculated at the level of 0.8. Primary end point = difference in thermic effect of food 'TEF' (kcal/min) over 180min. Results obtained from study previous studies indicated the incremental area under the TEF curve after regular eating was 25.8 (SD 6.8) kcal and after irregular eating was 14.8 (SD 11.7) kcal. With a cross-over design, 10 subjects in each group would be able to detect a change in TEF with the power of 80% at the level of 0.05 significance.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Regular | Experimental | Other: Regular meal patternRegular meal pattern |
| Irregular | Experimental | Other: Irregular meal patternIrregular meal pattern |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- Healthy;
- BMI 28 - 40 kg/m2
- Insulin resistance, HOMA ≥ 1.5
- Weight stable during the last 3 months (self-reported weight change < ± 2 kg)
Key exclusion criteria (10 listed)
- history of serious disease as assessed by a medical screening questionnaire
- taking any medication except for the oral contraceptive pill.
- Smokers
- high alcohol consumers (< 2-3 units/day),
- pregnant/lactating
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Regular meal patterna 14-day period of eating 6 meal per day | Other | Regular |
| Irregular meal patterna 14-day period of eating between 3 and 9 meal per day | Other | Irregular |
Primary outcome
Change in fasting insulin sensitivity, as measured by HOMA-IR
Time frame: 14 days
insulin sensitivity assessed using fasting circulating insulin and glucose concentration and the HOMA-insulin resistance (IR) index
5 secondary outcomes
Change in postprandial circulating insulin concentration
Time frame: 14 days
Change in thermic effect of food
Time frame: 14 days
Change in subjective appetite
Time frame: 14 days
Change in appetite hormones
Time frame: 14 days
Change in fasting cholesterol
Time frame: 14 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Mar 2018.
- Background: PubMed 15085170Farshchi HR, Taylor MA, Macdonald IA. Decreased thermic effect of food after an irregular compared with a regular meal pattern in healthy lean women. Int J Obes Relat Metab Disord. 2004 May;28(5):653-60. doi: 10.1038/sj.ijo.0802616.
- Background: PubMed 15220950Farshchi HR, Taylor MA, Macdonald IA. Regular meal frequency creates more appropriate insulin sensitivity and lipid profiles compared with irregular meal frequency in healthy lean women. Eur J Clin Nutr. 2004 Jul;58(7):1071-7. doi: 10.1038/sj.ejcn.1601935.
- Background: PubMed 15640455Farshchi HR, Taylor MA, Macdonald IA. Beneficial metabolic effects of regular meal frequency on dietary thermogenesis, insulin sensitivity, and fasting lipid profiles in healthy obese women. Am J Clin Nutr. 2005 Jan;81(1):16-24. doi: 10.1093/ajcn/81.1.16.
- Derived from this study: PubMed 34555151Alhussain MH, Macdonald IA, Taylor MA. Impact of isoenergetic intake of irregular meal patterns on thermogenesis, glucose metabolism, and appetite: a randomized controlled trial. Am J Clin Nutr. 2022 Jan 11;115(1):284-297. doi: 10.1093/ajcn/nqab323.
Related trials for Insulin Resistance
Not yet recruitingPhase 2
Effects of Meal Macronutrients on Postprandial Lipids
Nephrotic Syndrome, Lipodystrophy
RecruitingObservational study
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
Cushing Disease
Recruiting
Effects of Urolithin A Supplementation on Glucose Metabolism in Healthy Adults 55 >= Years Old: A Randomized Triple-Masked Controlled Clinical Trial
Healthy Volunteer
Recruiting
Multi-omics Dissection of Gut Microbiome Engraftment During FMT
Recurrent C. Difficile (rCDI), Ulcerative Colitis (UC)
RecruitingObservational study
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Asthma, Atherosclerosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ian A Macdonald, PhD principal investigator
University of Nottingham
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Regular meal pattern and Irregular meal pattern in people with Insulin Resistance, run by University of Nottingham at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in fasting insulin sensitivity, as measured by HOMA-IR (time frame: 14 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02582606, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2018.